WO2009030516A2 - Coloration pastel - Google Patents

Coloration pastel Download PDF

Info

Publication number
WO2009030516A2
WO2009030516A2 PCT/EP2008/053234 EP2008053234W WO2009030516A2 WO 2009030516 A2 WO2009030516 A2 WO 2009030516A2 EP 2008053234 W EP2008053234 W EP 2008053234W WO 2009030516 A2 WO2009030516 A2 WO 2009030516A2
Authority
WO
WIPO (PCT)
Prior art keywords
acid
mono
branched
saturated
weight
Prior art date
Application number
PCT/EP2008/053234
Other languages
German (de)
English (en)
Other versions
WO2009030516A3 (fr
Inventor
Astrid Kleen
Janie Terrier
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP08717966A priority Critical patent/EP2180923A2/fr
Publication of WO2009030516A2 publication Critical patent/WO2009030516A2/fr
Publication of WO2009030516A3 publication Critical patent/WO2009030516A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair

Definitions

  • the invention relates to a bleaching and dyeing method for human hair.
  • solid or paste-like preparations with solid oxidizing agents are usually mixed with a dilute hydrogen peroxide solution immediately before use. This mixture is then applied to the hair and rinsed again after a certain exposure time.
  • the present invention also relates to agents for dyeing and whitening keratin-containing fibers, in particular human hair.
  • Conventional hair dyes usually consist of at least one developer and at least one coupler substance and possibly even contain direct dyes as Nuanceure. Coupler and developer components are also referred to as oxidation dye precursors.
  • the developer components are usually primary aromatic amines with a further, located in the para or ortho position free or substituted hydroxy or amino group, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazolone and 2,4,5,6-tetraaminopyrimidine and its derivatives used.
  • m-phenylenediamine derivatives naphthols, resorcinol and resorcinol derivatives, pyrazolones, m-aminophenols and substituted pyridine derivatives are generally used.
  • the color change of non-blond hair towards brighter shades is usually due to oxidative lightening (bleaching) and simultaneous or subsequent staining.
  • the potential for damage to the keratinic fibers is very high due to the concentrated use of oxidizing agents.
  • the opening of the cuticle which is necessary for the whitening result, can in individual cases be accompanied by damage to the inner hair structure (corneum), in particular if bleaching is done frequently, for a very long time, or with very strong bleaching agents. This damage is due, for example, to the destruction and / or elution of melanin particles in the hair structure.
  • the fibers are treated with a separately formulated conditioner immediately after the color-changing treatment.
  • a preparation A comprising at least one oxidizing agent selected from hydrogen peroxide and its addition compounds to solid carriers, optionally with a preparation B containing at least one
  • Bleaching power o optionally mixed with a preparation C to an application preparation and o is applied to the keratinic fibers.
  • Step (ii) of the method according to the invention is the rinsing out of the bleaching agent preparation after a contact time t-i which is one to 45 minutes.
  • preparation C is a second preparation in the commercial product, and the consumer prepares the preparation for use by mixing preparation A with the preparation containing the other substance (preparation C) directly before use.
  • a sales packaging contains a preparation B and / or a preparation C in addition to preparation A
  • the application preparation is prepared by mixing and applied to the keratinic fibers (step 1 of the process according to the invention) and rinsed off again after a contact time t-i.
  • the bleaching agents preferably contain a solid peroxo compound.
  • This peroxo compound is in principle not limited; customary peroxo compounds known to the person skilled in the art are, for example, ammonium peroxydisulfate,
  • Sodium persulfate, percarbonates such as magnesium percarbonate, peroxides and perborates, urea peroxide and melamine peroxide are the inorganic compounds prefers.
  • Particularly preferred are the peroxydisulfates, in particular combinations of at least two peroxydisulfates.
  • Preferred bleaching agents are therefore characterized in that the solid peroxo compound is selected from ammonium and alkali metal persulfates and peroxidisulfates, with particularly preferred compositions according to the invention containing at least 2 different peroxydisulfates.
  • a particularly preferred bleaching agent (and thus a particularly preferred bleaching composition used in the process according to the invention) is characterized in that the bleaching powder contains as bleaching agent a solid bleaching agent selected from hydrogen peroxide addition compounds to solid supports, ammonium and alkali metal persulfates and peroxydisulfates.
  • a solid bleaching agent selected from hydrogen peroxide addition compounds to solid supports, ammonium and alkali metal persulfates and peroxydisulfates.
  • the peroxo compounds are present in the bleaching agents (and thus bleaching preparations used in the process according to the invention) preferably in amounts of from 1 to 80% by weight, preferably from 5 to 70% by weight, particularly preferably from 20 to 65% by weight and in particular from 35 to 60% by weight, based in each case on the total agent.
  • the bleaching agents may contain an alkalizing agent which serves to adjust the alkaline pH of the application mixture.
  • an alkalizing agent which serves to adjust the alkaline pH of the application mixture.
  • the usual alkalizing agents known to the person skilled in the art for bleaching agents such as ammonium, alkali metal and alkaline earth metal hydroxides, carbonates, bicarbonates, hydroxycarbonates, silicates, in particular metasilicates and alkali metal phosphates, can be used.
  • the bleaching agents (and thus preferred bleaching compositions used in the process according to the invention) comprise at least two different alkalizing agents. In this case, mixtures of, for example, a metasilicate and a hydroxycarbonate may be preferred.
  • the bleaching agents may contain further ingredients, for example complexing agents, phosphates, surfactants, emulsifiers, etc. These substances are described below since they may also be part of the developer dispersion, for example.
  • a particularly preferred group of ingredients that may be part of the bleaching powder are the bleach boosters.
  • Bleach boosters are preferably used to increase the bleaching action of the oxidizing agent, in particular the hydrogen peroxide. Suitable bleach boosters are (BV-i) compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids and / or optionally substituted perbenzoic acid, and / or
  • bleach amplifiers it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid.
  • Suitable substances are those which carry oxygen- and / or nitrogen-bonded acyl groups with the stated number of carbon atoms and / or optionally substituted benzoyl groups.
  • polyacylated alkylenediamines in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoylsuccinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate and 2,5-diacetoxy- 2,5-dihydrofuran.
  • TAED tetraacet
  • the carbonate or bicarbonate salts are preferably selected from at least one compound of the group consisting of ammonium, alkali (especially sodium and potassium), and Erdalkalicarbonatsalzen and bicarbonate salts.
  • Particularly preferred carbonate or bicarbonate salts are ammonium bicarbonate, ammonium carbonate, sodium bicarbonate, disodium carbonate, potassium bicarbonate, dipotassium carbonate. These particularly preferred salts can be used alone or in their mixtures of at least two representatives as bleaching amplifiers.
  • usable organic carbonates are selected from at least one compound of the group of carbonic acid monoesters and / or from at least one compound of the group of carbonic acid monoamides.
  • carbonic acid monoesters are the carbonic acid monoesters of the formula (BV-1),
  • R-O-C-OH Il 0 (BV-1) in which R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a Ci_ 6 alkyl group.
  • C 1 -C 6 -alkyl groups are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • compositions particularly preferably used according to the invention are characterized in that the radical R in formula (BV-1) is selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, isobutyl, ferf Butyl and hydroxymethyl and hydroxyethyl radicals.
  • Preferred carbonic acid monoamides are the compounds of the formula (BV-2),
  • R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably R is a C-. 6- alkyl group.
  • C 1 -C 6 -alkyl groups are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • Bleach enhancers of the formula (BV-2) which are particularly preferred according to the invention are characterized in that the radical R in formula (BV-2) is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-butyl, ferf-butyl and hydroxymethyl and hydroxyethyl radicals.
  • the acidic H atom of the carbonic acid monoester or monoamide may also be in neutralized form, i. salts of carbonic acid monoesters or carbonic acid monoamides can also be used according to the invention.
  • At least one compound selected from the group consisting of acetic acid, lactic acid, tartaric acid, citric acid, salicylic acid and orthophthalic acid may preferably be contained.
  • the bleach boosters are present in the bleaching agents (and thus in preferred bleaching preparations used in the process according to the invention) preferably in amounts of from 5 to 30% by weight, in particular in amounts of from 8 to 20% by weight, based in each case on the weight of the ready-to-use agent, contain.
  • the bleaching agent preparations are preferably obtained by mixing a bleaching powder with a developer dispersion.
  • This developer dispersion preferably contains at least one surfactant, with both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants being suitable in principle. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups as well as hydroxyl groups may be present in the molecule.
  • anionic surfactants and emulsifiers are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group, linear and branched fatty acids having 8 to 30 ° C Atoms (soaps),
  • R 1 CO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X is hydrogen, an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example acylglutamates, which are derived from fatty acids having 6 to 22, preferably 12 to 18, carbon atoms, for example C 12/14 or C 12/18 coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, in particular sodium N-cocoyl and sodium N-stearoyl-L-glutamate,
  • X is H or a -CH 2 COOR group
  • Y is H or -OH, under the condition that Y is H when X-CH 2 COOR
  • R, R 1 and R 2 are independently Hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified (C 6 -C 8 ) alkyl polysaccharides having 1 to 6 monomers Saccharide units and / or the etherified aliphatic (C 6 -C 16 ) -hydroxyalkylpolyols having 2 to 16 hydroxyl radicals, with the proviso that at least one of the groups R, R 1 or R 2 is a radical Z, esters of sulfosuccinic acid or Sulfosuccinates of the general formula (III), H 2 C - COOR 1 (III)
  • Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R- (O-CH 2 -CH 2 ) X -OSO 3 H, in which R is a preferably linear alkyl group of 8 to 30 carbon atoms and x 0 or 1 to 12, mixed hydroxysulfonate surfactants according to DE-A-37 25 030, esters of tartaric acid and citric acid with alcohols, the addition products of about 2- 15 molecules of ethylene oxide and / or propylene oxide to C 8 .
  • fatty alcohols alkyl and / or alkenyl ether phosphates, sulfated fatty acid alkylene glycol esters, monoglyceride sulfates and monoglyceride ether sulfates.
  • Preferred anionic surfactants and emulsifiers are acylglutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments of an octanoyl, decanoyl, lauroyl , Myristoyl, palmitoyl and stearoyl radical, esters of tartaric acid, citric acid or succinic acid or of the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco-Glucoside Tartrate and Disodium Coco-glucosides sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids having 8 to 18 carbon atoms in the alkyl group and up to 12 ethoxy groups in the
  • Zwitterionic surfactants and emulsifiers are surface-active compounds which have at least one quaternary ammonium group and at least one COO () or -SO 3 ' " ' group in the molecule
  • particularly suitable zwitterionic surfactants and Emulsifiers are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-ol Hydroxyethylimidazoline each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.
  • a preferred zwitterionic surfactant is the
  • quaternized cellulose derivatives such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, such as in particular the products sold under the trade name Cosmedia guar ® and Jaguar ® products, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.
  • the agents according to the invention can also contain amphoteric polymers. These additionally have at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers. In the context of the present invention, preferably usable zwitterionic polymers are composed essentially together
  • R 1 -CH CR 2 -CO-Z- (C n H 2n ) -N ( + ) R 3 R 4 R 5 A ⁇ - ) ( Z ⁇ ')
  • R 6 -CH CR 7 -COOH (Z-II) in which R "and R independently of one another are hydrogen or methyl groups.
  • Suitable starting monomers are, for. Dimethylaminoethylacrylamide, dimethylaminoethylmethacrylamide, dimethylaminopropylacrylamide,
  • Suitable monomeric carboxylic acids of the formula (Z-II) are acrylic acid, methacrylic acid, crotonic acid and 2-methylcrotonic acid. Preference is given to using acrylic or methacrylic acid, in particular acrylic acid.
  • the zwitterionic polymers which can be used according to the invention are prepared from monomers of the formulas (ZI) and (Z-II) by polymerization processes known per se.
  • the polymerization can be carried out either in aqueous or aqueous-alcoholic solution.
  • the alcohols used are alcohols having 1 to 4 carbon atoms, preferably isopropanol, which simultaneously serve as polymerization regulators.
  • other components than regulators may also be added to the monomer solution, eg.
  • formic acid or mercaptans such as thioethanol and thioglycolic acid.
  • the initiation of the polymerization takes place with the aid of free-radical-forming substances.
  • the polymerization can be carried out isothermally or under adiabatic conditions, depending on the concentration ratios by the heat of polymerization released, the temperature range for the course of the reaction between 20 and 200 0 C may vary, and the reaction may optionally be carried out under autogenous pressure.
  • the reaction temperature is between 20 and 100 0 C.
  • the pH during the copolymerization may vary within a wide range.
  • polymerization is carried out at low pH values; however, pH values above the neutral point are also possible.
  • an aqueous base for. As sodium hydroxide, potassium hydroxide or ammonia, to a pH between 5 and 10, preferably 6 to 8 set. Further details of the polymerization process can be found in the examples.
  • the anionic polymers (G2) are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid which is available for example under the name Rheothik ® 11-80 is commercially.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
  • Copolymers of maleic anhydride and methyl vinyl ether, in particular those with crosslinks, are also dye-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name Stabileze® QM ® commercially available.
  • the agents according to the invention may contain nonionic polymers (G4).
  • Suitable nonionic polymers are, for example:
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch;
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • Vinyl acetate / crotonic acid copolymers provided that they are stable as solids or preferably in
  • Active substances such as panthenol, pantothenic acid, allantoin, pyrrolidonecarboxylic acids and their salts,
  • Fats and waxes such as spermaceti, beeswax, montan wax, paraffins,
  • Swelling and penetration substances such as carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates,
  • compositions of the invention may also contain other ingredients.
  • oil components proved to be advantageous.
  • agents according to the invention additionally contain an oil component (D).
  • Oil components are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which may be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids (D1) it is possible to use linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • fatty alcohols (D2) it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 -, preferably C 10 -C 22 -and very particularly preferably C 12 -C 22 -carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reduction of naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (D3) it is possible according to the invention to use solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as, for example, apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent.
  • cosmetic oil bodies as ingredients of the compositions according to the invention.
  • the natural and synthetic cosmetic oil bodies (D4) include, for example: vegetable oils.
  • vegetable oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxo synthesis or the dimerization of unsaturated fatty acids.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, Gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols incurred.
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides.
  • the partial glycerides preferably follow the formula (D4-I),
  • R 1 , R 2 and R 3 independently of one another represent hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, carbon atoms, with the proviso that at least one of these groups represents a Acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • oleic acid monoglycerides are used.
  • agents according to the invention are particularly preferred which additionally contain an inert oil component, preferably from the group of esters of long-chain fatty acids, more preferably from the group of alkyloleates and / or alkyl stearates.
  • an inert oil component preferably from the group of esters of long-chain fatty acids, more preferably from the group of alkyloleates and / or alkyl stearates.
  • Suitable natural dyes are all dyes contained in plants, animals and microorganisms and recoverable from these, in particular those which have already been used for dyeing keratin fibers or hair.
  • An overview of natural dyes can be taken from Ullmann's Encyclopadie der ischen Chemie, 4th Edition (19), Volume 11, pages 100-134.
  • Natural dyes which are particularly preferred according to the invention are selected from henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, sedre and alkana root.
  • the natural dye (s) is / are selected from henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, sawnwood, madder root, catechu, seder and alkana root preferred according to the invention.
  • the natural dye (s) is / are selected from cinnamon, devil's claw, licorice, beetroot, blackberry, ratanhia, red sandalwood, blueberry, chamomile, rhubarb, cornflower, senna, galangal.
  • At least one natural product selected from henna red, henna neutral, henna black, chamomile, sandalwood, black tea, buckthorn bark, sage, sawnwood, madder root, catechu, sedre, alcano root, cinnamon , Devil's claw, liquorice, beetroot, blackberry, ratanhia, red sandalwood, blueberry, chamomile, rhubarb, cornflower, senna and galangal.
  • the colorant preparation used in the process according to the invention may contain substantive dyes.
  • Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • the substantive dyes are each preferably used in an amount of 0.001 to 20% by weight, based on the total application preparation. The total amount of substantive dyes is preferably at most 20% by weight.
  • Direct dyes can be subdivided into anionic, cationic and nonionic substantive dyes.
  • Particularly suitable anionic direct dyes are 6-hydroxy-5 - [(4-sulfophenyl) azo] -2-naphthalenesulfonic acid disodium salt (CI 15.985, Food Yellow No. 3, FD & C Yellow No. 6), 2,4-dinitro-1 -naphthol-7-sulfonic acid disodium salt (Cl.10.316; Acid Yellow 1, Food Yellow No. 1), 2- (indan-1, 3-dion-2-yl) quinoline-x, x-sulfonic acid (mixture of mono and disulfonic acid) (CI 47,005, D & C Yellow No. 10, Food Yellow No.
  • Phenylamino) -phenyl] -azobenzenesulfonic acid sodium salt (CI 13,065; Ki406; Acid Yellow 36), 9- (2-carboxyphenyl) -6-hydroxy-3H-xanthen-3-one (CI 45,350; Acid Yellow 73; D & C Yellow No 8), 5 - [(2,4-dinitrophenyl) amino] -2-phenylaminobenzenesulfonic acid, sodium salt (Cl.10, 385; Acid Orange 3), 4 - [(2,4-dihydroxyphenyl) azo] -benzenesulfonic acid, sodium salt (Cl Acid Orange 6), 4 - [(2-hydroxynaphth-1-yl) azo] -benzenesulfonic acid, sodium salt (Cl 15.510, Acid Orange 7), 4 - [(2,4-dihydroxy-3 - [( 2,4-dimethylphenyl) azo] -phenyl) azo] -benz
  • Acid Red 4 4-hydroxy-3 - [(4-sulfonaphth-1-yl) azo] -1-naphthalenesulfonic acid disodium salt (Cl 14.720; Acid Red No.14), 6-hydroxy-5 - [(4-sulfonaphth-1-yl) azo] -2,4-naphthalenedisulfonic acid trisodium salt (Cl 16,255, Ponceau 4R, Acid Red 18), 3-hydroxy-4 - [(4-sulfonaphth-1) yl) azo] -2,7-naphthalene-disulfonic acid trinatriu Msalz (Cl.
  • Acid Red 27 8-amino-1-hydroxy-2- (phenylazo) -3,6-naphthalenedisulfonic acid disodium salt (Cl 17,200, Acid Red 33, Red 33), 5- (acetylamino) -4-hydroxy 3 - [(2-methylphenyl) azo] -2,7-naphthalenedisulfonic acid disodium salt (Cl 18.065, Acid Red 35), 2- (3-hydroxy-2,4,5,7-tetraiododibenzopyran- 6-on-9-yl) benzoic acid disodium salt (Cl.45,430; Acid Red 51), N- [6- (diethylamino) -9- (2,4-disulfophenyl) -3H-xanthen-3-ylidene] - N-ethyleneamine ammonium hydroxide, inner salt, sodium salt (CI 45, 100, Acid Red 52), 8 - [(4- (phenylazo) phenyl) azo] -7-
  • Acid Red 95 2-hydroxy-3 - ((2-hydroxynaphth-1-yl) azo) -5-nitrobenzenesulfonic acid, sodium salt
  • Acid Red 184 3-hydroxy-4- (3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-ylazo) -naphthalene-1 sulfonic acid sodium salt, chromium complex (Acid Red 195), 3-hydroxy-4 - [(4-methyl-2-sulfonaphylene-azole) -naphthalenecarboxylic acid calcium salt (Cl 15.850: 1; Pigment Red 57: 1).
  • Betaine (CI 42,090, Acid Blue 9, FD & C Blue No. 1), 1-amino-4- (phenylamino) -9,10-anthraquinone-2-sulfonic acid (CI 62,055, Acid Blue 25), i-amino ⁇ ⁇ cyclohexylamino ⁇ ⁇ .iO-anthraquinone ⁇ -sulfonic acid sodium salt (CI 62045; Acid Blue 62), 2- (1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene) -2 , 3-dihydro-3-oxo-1H-indole-5-sulfonic acid disodium salt (Cl.
  • the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • R 1 and R 2 independently represent hydrogen or a methyl group and R, R and R ⁇ independently represent alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A ⁇ 'is the anion of an organic or inorganic acid
  • the acrylamidopropyltrimethylammonium chloride is a most preferred monomer of formula (Z-I).
  • the zwitterionic polymers which can be used according to the invention are prepared from monomers of the formulas (Z-I) and (Z-II) by polymerization processes known per se.
  • the polymerization can be carried out either in aqueous or aqueous-alcoholic solution.
  • the alcohols used are alcohols having 1 to 4 carbon atoms, preferably isopropanol, which simultaneously serve as polymerization regulators.
  • other components than regulators may also be added to the monomer solution, eg.
  • formic acid or mercaptans such as thioethanol and thioglycolic acid.
  • the initiation of the polymerization takes place with the aid of free-radical-forming substances.
  • amphoteric polymers according to the invention are:
  • the colorant preparations used in the process according to the invention may with particular preference contain one or more amino acids.
  • Particularly preferred amino acids which can be used according to the invention are from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, ⁇ Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-ally
  • Preferred colorant preparations used in the process according to the invention comprise one or more amino acids in narrower quantitative ranges.
  • preferred processes according to the invention are characterized in that the colorant preparation - based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.
  • vitamins, provitamins or vitamin precursors are vitamins, provitamins or vitamin precursors. These are described below:
  • vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include vitamin B 1 (thiamine) vitamin B 2 (riboflavin)
  • Vitamin B 3 Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent. Vitamin B 5 (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-cf] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • R 4 is -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 2 , -CH (CH 3 ) 2 , - (CH 2 ) 3 CH 3 ,
  • Preferred compounds of the formula (I) according to the invention are, for example
  • R 1 , R 2 , R 3 are each independently of one another -H, -CH 3 , -CH 2 CH 3 , - (C ⁇ 2 ) 2 C ⁇ 2 , -C ⁇ (C ⁇ 3 ) 2 , - (OH 2 J 3 OH 3 , - (_ / H ((_ / H 3 ) (- / H 2 (- / H 3 , -C ⁇ 2 (_ / H ((- / H 3 ) 2 , -C (CH 3 ) 3
  • R 4 is -CH 3 , or -CH 2 CH 3 , or - (CH 2 ) 2 CH 2 , or -CH (CH 3 ) 2 n is from 1 to 20, preferably from 2 to 15 and especially for 5, 6, 7, 8, 9, 10.
  • Particularly preferred methods according to the invention are characterized in that the colorant preparation - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0, 1 wt .-% at least a ubiquinone and / or contain at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
  • n 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
  • the colorant preparations used in the process according to the invention may also contain plastoquinones.
  • preferred colorant preparations used in the process according to the invention are characterized by being from 0.0002 to 4% by weight, preferably from 0.0005 to 3% by weight, particularly preferably from 0.001 to 2% by weight, more preferably from 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ib)
  • n stands for values of 1 to 20, preferably of 2 to 15 and in particular for 5, 6, 7, 8, 9, 10, whereby particularly preferred means Plastochinon PQ-9 of the formula
  • the colorant preparations used in the process according to the invention may contain purine and / or purine derivatives.
  • the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.
  • the colorant preparations used in the process according to the invention may therefore contain purine and / or derivative (s) of the purine.
  • Purine (7H-imidazo [4,5-cf] pyrimidine) does not occur freely in nature, but forms the main body of the purines.
  • Purines are a group of important compounds of widespread nature involved in human, animal, plant and microbial metabolic processes, which differ from the parent by substitution with OH, NH 2 , SH in the 2-, 6-, and 8-positions and / or with CH 3 in 1-, 3-, 7-position derived.
  • Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
  • Preferred colorant preparations used in the process according to the invention contain purine and / or purine derivatives in narrower quantitative ranges.
  • preferably used colorant preparations are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight. % and in particular 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • the purines and the purine derivatives are particularly preferred according to the invention. According to preferred methods are therefore characterized in that the colorant preparation - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s), preferred agents containing purine and / or purine derivative (s) of formula (Pur-I)
  • Agents according to the invention are preferred in which the weight ratio of ingredients a) and b) is from 10: 1 to 1: 100, preferably from 5: 1 to 1:50, particularly preferably from 2: 1 to 1:20 and in particular from 1: 1 to 1 : 10.
  • caffeine is a particularly preferred purine derivative
  • coenzyme Q10 is a particularly preferred biochinone.
  • Particularly preferred colorant preparations used in the process according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight. -% and in particular 0.01 to 0.1 wt .-% caffeine and 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.
  • the colorant preparations used in the process according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides.
  • preferred methods are characterized in that the colorant preparation - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt.
  • carbohydrate selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected from Monosaccharides, in particular
  • Trehalose and / or Cellobiose and / or gentiobiose and / or isomaltose Trehalose and / or Cellobiose and / or gentiobiose and / or isomaltose.
  • Particularly preferred colorant preparations used in the process according to the invention contain, based on their weight
  • Preferred colorant preparations used in the process according to the invention comprise one or more amino acids in narrower quantitative ranges.
  • preferred colorant preparations used in the process according to the invention are characterized in that they additionally contain from 0.05 to 5 wt.%, Preferably from 0.1 to 2.5 wt.%, Particularly preferably from 0.15 to 1 wt in particular 0.2 to 0.5 wt .-% amino acid (s), preferably (one) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine ,
  • R 15 and R 16 each represent hydrogen, methyl, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
  • R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or -or- or a diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
  • the compounds of the formulas (Fur-I) and (Fur-II) are used as intermediates in the synthesis of natural products and in the preparation of medicaments and vitamins.
  • the preparation of the active compounds according to the formulas (Fur-I) and (Fur-II) can be carried out, for example, by reacting primary alcohols with acrylic acids.
  • compounds of the formula (Fur-I) are obtained by reactions starting from hydroxypivaldehyde. Also, carbonylations of alkynes lead to substituted 2-furanones of the formula (Fur-I) or (Fur-II).
  • the compounds of the formula (Fur-I) or of the formula (Fur-II) can be obtained by intramolecular esterification of the corresponding hydroxycarboxylic acids.
  • the following compounds are on any of the previously indicated Synthetic pathways obtained: 2,5-dihydro-5-methoxy-2-furanone,
  • Preferred compounds of the formula (fur-I) and / or of the formula (fur-II) can be compounds in which the substituents R 1 , R 2 and R 7 independently of one another represent:
  • R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxy-hydrocarbon radical, a group -NR 12 R 13 , where R 12 and R 13 each independently represent hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
  • R 14 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
  • R 17 is a methyl, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a - C 2 - C 30 - saturated or on or - polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxyalkylrest, or a -C 2 - C 30 - saturated or on or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical.
  • Hydrogen an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl, a -C 2 -C 4 - saturated or mono- or diunsaturated, branched or linear
  • R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
  • R 14 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
  • R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 - C 4 - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
  • R 17 is a methyl, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a - C 2 - C 30 - saturated or on or - polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxykohlenwasserstoffrest.
  • Hydrogen an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl, a -C 2 -C 4 - saturated or mono- or diunsaturated, branched or linear
  • Mono-, di- or trihydroxyhydrocarbyl radical a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or or diunsaturated, branched or linear mono-, di- or
  • Trihydroxy hydrocarbon residue a group -COOR 14 , wherein R 14 is hydrogen, a methyl, a -C 2 -C 4 - saturated or mono- or diunsaturated, branched or linear
  • Hydrocarbon radical a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a group -OCOR 17 , wherein R 17 is a methyl, a -C 2 -C 30 saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a
  • radicals R 5 and R 6 may furthermore be advantageous for the compounds of the formula (Fur I) for the radicals R 5 and R 6 to stand independently for: a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear
  • Mono-, di- or trihydroxyhydrocarbyl radical a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or or diunsaturated, branched or linear mono-, di- or
  • the colorant preparation additionally contains 0.001 to 5 wt.%, Preferably 0.01 to 4 wt.%, Particularly preferably 0.02 to 2.5 wt.% And in particular 0.1 to 1 , 5% by weight of bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un procédé permettant la modification de la couleur de fibres contenant de la kératine, en particulier des cheveux humains, évitant sensiblement l'endommagement des cheveux et permettant de 'réparer' au moins partiellement des dommages déjà commis, c'est-à-dire de renforcer la structure des cheveux. Le procédé de l'invention comprend les étapes suivantes, directement consécutives et sans étapes intermédiaires: (i) appliquer une préparation d'agents de décoloration sur les fibres contenant de la kératine et laisser poser ladite préparation de une à 45 minutes; (ii) rincer la préparation d'agent de décoloration; et (iii) appliquer une autre préparation à base de colorant, qui contient au moins un colorant naturel; (iv) rincer ladite préparation.
PCT/EP2008/053234 2007-08-31 2008-03-18 Coloration pastel WO2009030516A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08717966A EP2180923A2 (fr) 2007-08-31 2008-03-18 Coloration pastel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041493.7 2007-08-31
DE102007041493A DE102007041493A1 (de) 2007-08-31 2007-08-31 Pastellfärbung

Publications (2)

Publication Number Publication Date
WO2009030516A2 true WO2009030516A2 (fr) 2009-03-12
WO2009030516A3 WO2009030516A3 (fr) 2009-06-04

Family

ID=40299055

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/053234 WO2009030516A2 (fr) 2007-08-31 2008-03-18 Coloration pastel

Country Status (3)

Country Link
EP (1) EP2180923A2 (fr)
DE (1) DE102007041493A1 (fr)
WO (1) WO2009030516A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114630652A (zh) * 2019-10-31 2022-06-14 花王株式会社 包含黄嘌呤衍生物的含水氧化组合物

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103161A1 (fr) * 2009-03-12 2010-09-16 Jose Chafer Jose Luis Nouvelle formulation pour la teinture des cheveux, teinture pour les cheveux et dispositif d'application
ES2350080B1 (es) * 2009-05-12 2011-12-19 Jose Luis Jose Chafer Nueva formulacion para el tinte del cabello.
GB0908397D0 (en) * 2009-05-15 2009-06-24 Univ Leeds Natural hair dyes
DE102010045185A1 (de) * 2010-09-13 2012-03-15 Marianne Broendlund Stoffgemisch, Verwendung und Infusionslösung
WO2012159918A1 (fr) * 2011-05-25 2012-11-29 Unilever Plc Produit de coloration pour les cheveux comprenant des ions métalliques et un composant provenant des myrtilles
WO2021084055A1 (fr) 2019-10-31 2021-05-06 Kao Germany Gmbh Composition de poudre de blanchiment
BR112022008396A2 (pt) * 2019-10-31 2022-07-19 Kao Corp Composição de tingimento oxidativo de duas partes
EP3815673B1 (fr) * 2019-10-31 2022-09-07 Kao Germany GmbH Composition de décoloration en deux parties
WO2022229171A1 (fr) * 2021-04-26 2022-11-03 Kao Corporation Produit cosmétique pour teindre des fibres kératiniques
TW202308585A (zh) * 2021-04-26 2023-03-01 日商花王股份有限公司 用於染色角蛋白纖維之化妝品產品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341647A1 (de) * 1993-12-07 1995-06-08 Hartmann Haarkosmetik Gmbh Haarbehandlungsmittel und Verfahren, insbesondere zum Zwecke der Herstellung und Anwendung haarpflegender, homogener und ausgezeichnet auftragbarer gebrauchsfertiger Pflanzenhaarfarben-Zubereitungen
EP0821935A2 (fr) * 1996-08-01 1998-02-04 Wella Aktiengesellschaft Composition pour la coloration ou teinture des cheveux
WO2001072271A2 (fr) * 2000-03-27 2001-10-04 The Procter & Gamble Company Compositions stables alcalines de decoloration et de coloration capillaire et procede d'utilisation
EP1269975A2 (fr) * 2001-06-29 2003-01-02 GOLDWELL GmbH Teinture pour cheveux
DE10150445A1 (de) * 2001-10-12 2003-04-17 Beiersdorf Ag Verwendung einer oder mehreren Substanzen, gewählt aus der Gruppe der Pyrimidine und Purine in kosmetischen Zubereitungen zur Haarfärbung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725030A1 (de) 1987-07-29 1989-02-09 Henkel Kgaa Oberflaechenaktive hydroxysulfonate
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
DE10031706A1 (de) * 2000-06-29 2002-01-17 Goldwell Gmbh Mittel zur Pflege und Behandlung von menschlichen Haaren
US6926886B2 (en) * 2002-10-31 2005-08-09 Johnson & Johnson Consumer Companies, Inc. Compositions for darkening the skin and/or hair

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341647A1 (de) * 1993-12-07 1995-06-08 Hartmann Haarkosmetik Gmbh Haarbehandlungsmittel und Verfahren, insbesondere zum Zwecke der Herstellung und Anwendung haarpflegender, homogener und ausgezeichnet auftragbarer gebrauchsfertiger Pflanzenhaarfarben-Zubereitungen
EP0821935A2 (fr) * 1996-08-01 1998-02-04 Wella Aktiengesellschaft Composition pour la coloration ou teinture des cheveux
WO2001072271A2 (fr) * 2000-03-27 2001-10-04 The Procter & Gamble Company Compositions stables alcalines de decoloration et de coloration capillaire et procede d'utilisation
EP1269975A2 (fr) * 2001-06-29 2003-01-02 GOLDWELL GmbH Teinture pour cheveux
DE10150445A1 (de) * 2001-10-12 2003-04-17 Beiersdorf Ag Verwendung einer oder mehreren Substanzen, gewählt aus der Gruppe der Pyrimidine und Purine in kosmetischen Zubereitungen zur Haarfärbung

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C. CARTWRIGHT-JONES: HENNA FOR HAIR "HOW TO", [Online] 2006, XP002522782 Gefunden im Internet: URL:http://www.hennaforhair.com/freebooks/hennaforhair.pdf> [gefunden am 2009-04-03] *
See also references of EP2180923A2 *
VIVASAN: "Ratgerber zu Vivasan"[Online] 2005, XP002522783 Gefunden im Internet: URL:http://www.vivasan.eu/files/download/de/RATGERBER.pdf> [gefunden am 2009-04-03] *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114630652A (zh) * 2019-10-31 2022-06-14 花王株式会社 包含黄嘌呤衍生物的含水氧化组合物
CN114630652B (zh) * 2019-10-31 2024-05-14 花王株式会社 包含黄嘌呤衍生物的含水氧化组合物

Also Published As

Publication number Publication date
WO2009030516A3 (fr) 2009-06-04
DE102007041493A1 (de) 2009-03-05
EP2180923A2 (fr) 2010-05-05

Similar Documents

Publication Publication Date Title
WO2009030516A2 (fr) Coloration pastel
EP2211832B1 (fr) Agents de traitement capillaire, notamment produits coiffants, contenant deux copolymères
DE102008061133A1 (de) Verstärkte Aufhellung bei gleichzeitiger Haarkräftigung
DE102008046433A1 (de) Aufhellmittel mit 2-Acylpyridinium-Derivaten
DE102008057018A1 (de) Kombination von kationischen Bleichaktivatoren und Farbstoffen
DE102007036499A1 (de) Naturkosmetisches Haarbehandlungsmittel
EP1232739A1 (fr) Combinaisons de principes actifs comprenant des hydrocarbures et des ingrédients huileux dans une composition cosmétique
EP2061563A2 (fr) Mousse de nuançage
DE102008061046A1 (de) Haarfärbemittel mit Farbindikator
DE102008036535A1 (de) Coloration mit kationisierbaren Polymer
DE102008032208A1 (de) Oxidationsfärbemittel mit basischer Aminosäure, Ammoniumsulfat und Alkanolaminen
DE102008060670A1 (de) Alternative Oxidationsmittel
DE102008060671A1 (de) Beschleunigte Aufhellmittel
DE102008032178A1 (de) Oxidationsfärbemittel mit Gelbasis aus hochethoxylierten Fettalkoholen und polysaccharidischem Verdicker für pH-reduzierte Expressfärbung
DE102004030885A1 (de) Haarreinigungsmittel mit aminofunktionellen Siliconen
EP1696870B1 (fr) Agent de teinture en tubes
EP1813259B1 (fr) Composition déclaircissement et/ou de coloration ayant un potentiel d'irritation réduit
WO2009010415A2 (fr) Agents contenant un principe actif anti-irritant
WO2009030518A1 (fr) Agents éclaircissants et procédé d'éclaircissement
DE102007053950A1 (de) Mittel mit Bioflavonoid
EP1438007A1 (fr) Nouvelle utilisation de tensioactifs derives du sucre et de glycerides partiels d'acides gras dans des colorants
WO2012038114A2 (fr) Conservation de la couleur à l'aide d'agents de conditionnement contenant des agents de réduction
DE102008036717A1 (de) Farbgebende Conditioner
DE102008038138A1 (de) Farbige Haarbehandlungsmittel
DE102007027862A1 (de) Verfahren zur Abfüllung haarfarbverändernder Mittel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08717966

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008717966

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE